• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者的膳食钙摄入量。

Dietary calcium intake in patients with inflammatory bowel disease.

作者信息

Vernia Piero, Loizos Panagiotis, Di Giuseppantonio Irene, Amore Barbara, Chiappini Ambra, Cannizzaro Santi

机构信息

Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome, Italy.

Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome, Italy.

出版信息

J Crohns Colitis. 2014 Apr;8(4):312-7. doi: 10.1016/j.crohns.2013.09.008. Epub 2013 Oct 3.

DOI:10.1016/j.crohns.2013.09.008
PMID:24090907
Abstract

BACKGROUND & AIMS: Osteopenia and increased risk for fractures in IBD result from several factors.

AIM OF THE STUDY

To investigate the dietary intake of calcium in IBD patients.

METHODS

A 22-item quantitative validated frequency food questionnaire was used for quantifying dietary calcium in relation to gender and age, in 187 IBD patients, 420 normal- and 276 diseased controls.

STATISTICAL ANALYSIS

Mann-Whitney, chi-square- and T-tests.

RESULTS

The mean calcium intake was 991.0 ± 536.0 (105.8% Recommended Daily Allowances) and 867.6 ± 562.7 SD mg/day (93.8% RDA) in healthy and diseased controls, and 837.8 ± 482.0 SD mg/day (92.7% RDA) in IBD, P<0.001. Calcium intake was high in celiac disease (1165.7 ± 798.8 SD mg/day, 120% RDA), and non-significantly lower in ulcerative colitis than in Crohn's disease (798.7 ± 544.1 SD mg/day vs 881.9 ± 433.0). CD and UC females, but not males, had a mean calcium intake well under RDA. In all study groups the intake was lower in patients believing that consumption of lactose-containing food induced symptoms, versus those who did not (105.8% vs 114.3% RDA in normal controls; 100.4% vs 87.6% RDA in IBD).

CONCLUSIONS

Diet in IBD patients contained significantly less calcium than in healthy controls. Gender and age, more than diagnosis, are central in determining inadequate calcium intake, more so in IBD. Self-reported lactose intolerance, leading to dietary restrictions, is the single major determinant of low calcium intake. Inadequate calcium intake is present in one third of IBD patients and represents a reversible risk factor for osteoporosis, suggesting the need for tailored nutritional advice in IBD.

摘要

背景与目的

炎症性肠病(IBD)患者出现骨质减少和骨折风险增加是由多种因素导致的。

研究目的

调查IBD患者的钙膳食摄入量。

方法

采用一份经过验证的包含22个项目的定量食物频率问卷,对187例IBD患者、420例正常对照者和276例疾病对照者的膳食钙摄入量按性别和年龄进行量化。

统计分析

采用曼-惠特尼检验、卡方检验和t检验。

结果

健康对照者和疾病对照者的平均钙摄入量分别为991.0±536.0(占推荐每日摄入量的105.8%)和867.6±562.7标准差毫克/天(占推荐每日摄入量的93.8%),IBD患者为837.8±482.0标准差毫克/天(占推荐每日摄入量的92.7%),P<0.001。乳糜泻患者的钙摄入量较高(1165.7±798.8标准差毫克/天,占推荐每日摄入量的120%),溃疡性结肠炎患者的钙摄入量略低于克罗恩病患者,但差异无统计学意义(798.7±544.1标准差毫克/天对881.9±433.0)。IBD女性患者(而非男性患者)的平均钙摄入量远低于推荐每日摄入量。在所有研究组中,认为食用含乳糖食物会引发症状的患者的钙摄入量低于不这么认为的患者(正常对照者中分别为占推荐每日摄入量的105.8%对114.3%;IBD患者中分别为占推荐每日摄入量的100.4%对87.6%)。

结论

IBD患者饮食中的钙含量显著低于健康对照者。在决定钙摄入量不足方面,性别和年龄比疾病诊断更为关键,在IBD患者中更是如此。自我报告的乳糖不耐受导致饮食限制,是钙摄入量低的唯一主要决定因素。三分之一的IBD患者存在钙摄入不足的情况,这是骨质疏松症的一个可逆转风险因素,提示IBD患者需要针对性的营养建议。

相似文献

1
Dietary calcium intake in patients with inflammatory bowel disease.炎症性肠病患者的膳食钙摄入量。
J Crohns Colitis. 2014 Apr;8(4):312-7. doi: 10.1016/j.crohns.2013.09.008. Epub 2013 Oct 3.
2
Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.中国炎症性肠病成年患者的维生素 D 水平和骨代谢。
J Dig Dis. 2014 Mar;15(3):116-23. doi: 10.1111/1751-2980.12118.
3
[Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].[慢性炎症性肠病中的病理性骨密度——患病率及危险因素]
Z Gastroenterol. 1999 Jan;37(1):5-12.
4
Low Vitamin K and Vitamin D Dietary Intake in Patients with Inflammatory Bowel Diseases.炎症性肠病患者的维生素 K 和维生素 D 膳食摄入量低。
Nutrients. 2023 Mar 30;15(7):1678. doi: 10.3390/nu15071678.
5
[Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].[炎症性肠病中的骨质疏松症——德国克罗恩病和溃疡性结肠炎协会成员的调查结果]
Z Gastroenterol. 2003 Dec;41(12):1145-50. doi: 10.1055/s-2003-45280.
6
Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India.印度一家三级医疗机构中炎症性肠病患者的骨密度评估。
Indian J Gastroenterol. 2008 May-Jun;27(3):103-6.
7
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.免疫调节剂与抗TNFα药物联合治疗可改善炎症性肠病患者的骨密度。
J Crohns Colitis. 2014 Dec;8(12):1693-701. doi: 10.1016/j.crohns.2014.08.004. Epub 2014 Aug 27.
8
Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.罗马尼亚东北部炎症性肠病患者的骨矿物质密度
Rev Med Chir Soc Med Nat Iasi. 2013 Jan-Mar;117(1):23-8.
9
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.炎症性肠病中骨代谢的改变:克罗恩病与溃疡性结肠炎存在差异。
J Intern Med. 2000 Jan;247(1):63-70. doi: 10.1046/j.1365-2796.2000.00582.x.
10
[The risk factor for low bone mineral density in patients with inflammatory bowel disease].[炎症性肠病患者低骨矿物质密度的危险因素]
Zhonghua Nei Ke Za Zhi. 2009 Oct;48(10):833-6.

引用本文的文献

1
What the Patient Thinks and What the Patient Does: Placebo, Nocebo, and Therapy Adherence in Ulcerative Colitis.患者的想法与行为:溃疡性结肠炎中的安慰剂、反安慰剂与治疗依从性
J Clin Med. 2025 Jun 18;14(12):4351. doi: 10.3390/jcm14124351.
2
Nutritional Deficiencies and Reduced Bone Mineralization in Ulcerative Colitis.溃疡性结肠炎中的营养缺乏与骨矿化降低
J Clin Med. 2025 May 6;14(9):3202. doi: 10.3390/jcm14093202.
3
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.肠道、骨骼与肌肉:炎症性肠病中的骨肌减少三联征
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
4
Metabolic musculoskeletal disorders in patients with inflammatory bowel disease.炎症性肠病患者的代谢性肌肉骨骼疾病
Korean J Intern Med. 2025 Mar;40(2):181-195. doi: 10.3904/kjim.2024.359. Epub 2025 Mar 1.
5
Nutritional Support: The Use of Antioxidants in Inflammatory Bowel Disease.营养支持:抗氧化剂在炎症性肠病中的应用。
Int J Mol Sci. 2024 Apr 16;25(8):4390. doi: 10.3390/ijms25084390.
6
Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease.辅助治疗炎症性肠病的微量营养素补充。
Front Immunol. 2023 Apr 3;14:1143123. doi: 10.3389/fimmu.2023.1143123. eCollection 2023.
7
Low Vitamin K and Vitamin D Dietary Intake in Patients with Inflammatory Bowel Diseases.炎症性肠病患者的维生素 K 和维生素 D 膳食摄入量低。
Nutrients. 2023 Mar 30;15(7):1678. doi: 10.3390/nu15071678.
8
Nutritional interventions in adult fibrostenotic Crohn's disease: A systematic review.成人纤维狭窄型克罗恩病的营养干预:一项系统综述。
Front Nutr. 2023 Feb 21;10:1017382. doi: 10.3389/fnut.2023.1017382. eCollection 2023.
9
Global attitudes on and the status of enteral nutrition therapy for pediatric inflammatory bowel disease.全球对儿童炎症性肠病肠内营养治疗的态度及现状
Front Med (Lausanne). 2022 Dec 8;9:1036793. doi: 10.3389/fmed.2022.1036793. eCollection 2022.
10
Nutrient Intake of Crohn's Patients: Is There Consistency between Crohn's Disease Activity Index, Subjective Global Assessment and Body Mass Index?克罗恩病患者的营养摄入:克罗恩病活动指数、主观全面评定法与体重指数之间是否具有一致性?
Iran J Public Health. 2021 Dec;50(12):2584-2592. doi: 10.18502/ijph.v50i12.7942.